#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Obesity Acquired C1 inhibitor deficiency Type IIa hyperlipidaemia Kawasaki's disease Marfan's syndrome Colitis ulcerative Progressive supranuclear palsy Hyperinsulinaemic hypoglycaemia Autoimmune disorder Gaucher's disease type I Selective polysaccharide antibody deficiency Vascular malformation Gastrointestinal neuroendocrine tumour Peritoneal mesothelioma malignant Myelodysplastic syndrome More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage III – Treatment Wolfram syndrome MELAS syndrome – Trials in Disease Familial amyotrophic lateral sclerosis – Diagnostics Cystic fibrosis lung – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Basic Information Hereditary angioedema – Treatment Fabry’s disease Short-bowel syndrome – Trials in Disease Congenital hypotransferrinaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Enpatoran VAMIFEPORT TRIHYDROCHLORIDE RP2 Enx-101 Escitalopram Oxalate Cetirizine Ertugliflozin Streptococcus Pneumoniae Adrenaline Tartrate Ph. Eur. L-Glutamic Acid VG801-1 TUB-030 Vancomycin Hydrochloride Cytisine Voriconazole Diclofenac ATIGOTATUG Mirtazapine ZODASIRAN Procarbazine More therapies…

    Learn about Your Condition

    Systemic infection Microscopic polyangiitis Bipolar disorder Ventricular extrasystoles Hyperadrenocorticism Spinal cord injury cervical Lyme disease Pancoast's tumour Metastases to rectum Herpes virus infection Hyperkalaemia Limb reduction defect Usher's syndrome Myxofibrosarcoma Pulmonary tuberculosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Asthma

  • Efficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations

    Recruiting

    3 1 1
    Investigated Drugs:
    • Depemokimab
    Belgium Bulgaria Czechia France Germany Ireland +3

  • Efficacy and Safety of Inhaled Glycopyrronium Bromide Added to Budesonide and Formoterol Fumarate in Children 4‑12 Years with Asthma (Placebo‑Controlled)

    Recruiting

    2 1
    Investigated Drugs:
    • Budesonide
    • Formoterol Fumarate
    • Glycopyrronium Bromide
    Czechia Hungary Poland

  • Efficacy and safety of GB-0895 as adjunctive therapy in adults and adolescents with severe uncontrolled asthma (randomized, placebo‑controlled)

    Recruiting

    3 1
    Belgium Estonia France Ireland Italy Slovakia +1

  • GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

    Recruiting

    3 1
    Investigated Diseases:
    • Asthma
    Bulgaria Croatia Czechia Germany Greece Hungary +4

  • A study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma

    Recruiting

    2 1
    Investigated Diseases:
    • Asthma
    Austria Belgium Germany Italy Poland Romania +2

  • Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate
    • Beclometasone Dipropionate Anhydrous
    • Formoterol Fumarate Dihydrate
    Bulgaria Czechia Germany Hungary Latvia Poland +2
1 2 3 … 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!